Investment and media industries quickly "taught" us all to focus our attention on stock prices and short-term gains and ...

Global physically-backed gold ETFs racked up their largest six-month inflow since H1 2020 in this year's January-to-June ...

Capital Group Growth trades at cheaper valuations than index-focused growth ETFs, with a strong quant rating and attractive ...

Emergent BioSolutions (EBS) has secured a $51.9M contract modification award to deliver CNJ-016 to the Administration for Strategic Preparedness and Response (A ...

Vor Biopharma pivots to telitacicept with $175M funding, eyeing multi-billion potential. Risks include dilution, regulatory ...

Toll Brothers (TOL) is forming a joint venture with International Capital, LLC to develop a three-story, 348-unit luxury ...

Apogee Therapeutics, Inc.'s APG777 shows promising week-16 efficacy and dosing potential, targeting the AT market. Click for ...

Brookfield Asset Management is set to become the largest private investor in UK's Sizewell C nuclear project and EDF will cut ...

STRF combines Bitcoin-linked upside and fixed-income stability in a structurally senior preferred security that remains ...

Meta Platforms (META) has acquired a small non-controlling stake in eyewear holding company EssilorLuxottica (ESLOF) (ESLOY), ...

Goldman Sachs (GS) tapped former U.K. Prime Minister Rishi Sunak for a senior advisory role, marking a return to the Wall ...

FDA approval of EKTERLY makes KalVista Pharmaceuticals, Inc. the first to offer an oral on-demand HAE therapy. Click here to find out why KALV is a Strong Buy.